ArticleCancers2022

Oral Etoposide and Trastuzumab Use for HER2-Positive Metastatic Breast Cancer: A Retrospective Study from the Institut Curie Hospitals.

Clelia Chalumeau et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.